The bacteriocin haemocin is produced by most type b strains of Haemophilus influenzae, including strains of diverse genetic lineage, and is toxic to virtually all nontypeable H. influenzae strains. An H. influenzae transformant bearing a plasmid with a 1.5-kbp chromosomal fragment capable of conferring haemocin immunity on a haemocin-susceptible H. influenzae mutant was selected by using partially purified haemocin. Deletional and site-directed mutagenesis localized the haemocin immunity gene to the 3 open reading frame (ORF) within this chromosomal fragment. Subcloning of this ORF demonstrated that it was sufficient to confer haemocin immunity on wild-type haemocin-susceptible H. influenzae strains as well as haemocin-susceptible strains of Escherichia coli. This ORF, designated hmcI, encodes a 105-amino-acid protein with an estimated molecular mass of 12.6 kDa. Primer extension analysis revealed a putative transcriptional start site 34 bp upstream of the start codon, and the presence of a promoter immediately upstream of hmcI was confirmed by cloning the gene into a promoterless chloramphenicol acetyltransferase vector. To characterize the hmcI gene product, a His-HmcI fusion protein was constructed.Most type b-encapsulated strains of Haemophilus influenzae, including strains demonstrated to be genetically diverse by multilocus enzyme electrophoresis (22), produce the bacteriocin haemocin (HMC), which is toxic in vitro to virtually all non-type b strains of H. influenzae, both encapsulated and nonencapsulated (16,37,38). Data suggest that HMC exerts its toxicity by inhibiting DNA synthesis in susceptible strains (34); however, little is known about the genetic determinants conferring HMC production or immunity in H. influenzae.Bacterial cells capable of bacteriocin production must be immune to the toxic effects of the bacteriocin protein. This immunity is usually mediated via the coproduction of a specific immunity protein. A number of bacteriocin immunity genes have been cloned and characterized. The majority of these are located within gene clusters that also encode bacteriocin structural, transporter, and accessory proteins (1,14,26). Although they generally encode relatively small peptides, little homology has been observed among characterized bacteriocin immunity genes. In this report, we describe the identification, characterization, and heterologous expression of hmcI, the gene responsible for conferring immunity against the H. influenzae bacteriocin HMC.
MATERIALS AND METHODSBacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids used are listed in Table 1. Escherichia coli strains were cultivated in LuriaBertani medium (LB) with appropriate antibiotics. Antibiotic concentrations (in micrograms per milliliter) used for plasmid selection in E. coli were as follows: carbenicillin, 40 to 50; chloramphenicol, 20 to 25; and ribostamycin, 40. H. influenzae strains were grown in brain heart infusion broth supplemented with 10 g of hemin and 10 g of -NAD (Sigma Chemical Co., St. Lou...